Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-066889
Filing Date
2025-05-08
Accepted
2025-05-08 16:00:27
Documents
68
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q lgvn-20250331.htm   iXBRL 10-Q 1781734
2 EX-31.1 lgvn-ex31_1.htm EX-31.1 13469
3 EX-31.2 lgvn-ex31_2.htm EX-31.2 13489
4 EX-32.1 lgvn-ex32_1.htm EX-32.1 13517
5 GRAPHIC img238710588_0.jpg GRAPHIC 199858
  Complete submission text file 0000950170-25-066889.txt   8650553

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT lgvn-20250331.xsd EX-101.SCH 1208296
71 EXTRACTED XBRL INSTANCE DOCUMENT lgvn-20250331_htm.xml XML 1324318
Mailing Address 1951 NW 7TH AVENUE SUITE 520 MIAMI FL 33136
Business Address 1951 NW 7TH AVENUE SUITE 520 MIAMI FL 33136 305-302-7158
Longeveron Inc. (Filer) CIK: 0001721484 (see all company filings)

EIN.: 472174146 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40060 | Film No.: 25925793
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)